Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

5.820 -0.510 (-8.06%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 507,475
Open 6.540
Bid (Size) 5.790 (5)
Ask (Size) 6.000 (5)
Prev. Close 6.330
Today's Range 5.740 - 6.540
52wk Range 4.090 - 11.52
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now
Exscientia has the potential to be a star collaborator and a profitable drug developer, too. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+3.74%
+3.74%
1 Month
+0.69%
+0.69%
3 Month
+2.83%
+2.83%
6 Month
-29.37%
-29.37%
1 Year
+16.40%
+16.40%

More News

Read More
Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza
From Exscientia plc
Via Business Wire
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
From Exscientia plc
Via Business Wire
Earnings Outlook For Exscientia
Via Benzinga
Analyst Expectations for Exscientia's Future
Via Benzinga
Unlocking AI investment opportunities in healthcare
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
3 Cutting-Edge Biotech Stocks for the Bold Investor
Via InvestorPlace
Exscientia Business Update for Third Quarter 2023
From Exscientia plc
Via Business Wire
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023
From Exscientia plc
Via Business Wire
3 Trends in Artificial Intelligence to Watch in 2024
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Parker Moss to Join Exscientia as EVP, Corporate Development
From Exscientia plc
Via Business Wire
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023
From Exscientia plc
Via Business Wire
AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Exscientia Details Pipeline Prioritisation Strategy
From Exscientia plc
Via Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
FedEx, Splunk, FactSet Research And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Exscientia Shares Surge On AI Collaboration: The Details
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
From Exscientia plc
Via Business Wire
3 AI Drug Discovery Stocks to Watch
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Med Tech Stocks That the AI Boom Will Only Help
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.